Integral Health Asset Management as of Sept. 30, 2021
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 70 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Arena Pharmaceuticals Com New | 5.1 | $18M | 300k | 59.55 | |
Acadia Healthcare (ACHC) | 4.7 | $16M | 255k | 63.78 | |
Sage Therapeutics (SAGE) | 4.1 | $14M | 319k | 44.31 | |
CVS Caremark Corporation (CVS) | 3.7 | $13M | 150k | 84.86 | |
Cytokinetics Com New (CYTK) | 3.3 | $12M | 325k | 35.74 | |
Globus Med Cl A (GMED) | 3.3 | $12M | 150k | 76.62 | |
Pfizer (PFE) | 3.1 | $11M | 250k | 43.01 | |
Blueprint Medicines (BPMC) | 2.9 | $10M | 98k | 102.81 | |
Medtronic SHS (MDT) | 2.9 | $10M | 80k | 125.35 | |
Envista Hldgs Corp (NVST) | 2.8 | $9.6M | 230k | 41.81 | |
Anthem (ELV) | 2.7 | $9.3M | 25k | 372.80 | |
Hologic (HOLX) | 2.5 | $8.9M | 120k | 73.81 | |
Zimmer Holdings (ZBH) | 2.5 | $8.8M | 60k | 146.37 | |
PerkinElmer (RVTY) | 2.5 | $8.7M | 50k | 173.30 | |
Seagen | 2.0 | $6.8M | 40k | 169.80 | |
Intellia Therapeutics (NTLA) | 1.9 | $6.7M | 50k | 134.16 | |
Horizon Therapeutics Pub L SHS | 1.9 | $6.6M | 60k | 109.53 | |
Apellis Pharmaceuticals (APLS) | 1.8 | $6.3M | 190k | 32.96 | |
Centene Corporation (CNC) | 1.8 | $6.2M | 100k | 62.31 | |
Regeneron Pharmaceuticals (REGN) | 1.7 | $6.1M | 10k | 605.20 | |
Zentalis Pharmaceuticals (ZNTL) | 1.7 | $6.0M | 90k | 66.64 | |
Fate Therapeutics (FATE) | 1.6 | $5.6M | 95k | 59.27 | |
Dex (DXCM) | 1.6 | $5.5M | 10k | 546.90 | |
Chemocentryx | 1.5 | $5.1M | 300k | 17.10 | |
Lifestance Health Group (LFST) | 1.5 | $5.1M | 350k | 14.50 | |
AmerisourceBergen (COR) | 1.4 | $4.8M | 40k | 119.45 | |
Alnylam Pharmaceuticals (ALNY) | 1.4 | $4.7M | 25k | 188.80 | |
Agilon Health (AGL) | 1.4 | $4.7M | 180k | 26.21 | |
Natera (NTRA) | 1.3 | $4.5M | 40k | 111.45 | |
Relay Therapeutics (RLAY) | 1.3 | $4.4M | 140k | 31.53 | |
Heron Therapeutics (HRTX) | 1.3 | $4.4M | 410k | 10.69 | |
Universal Hlth Svcs CL B (UHS) | 1.2 | $4.2M | 30k | 138.37 | |
Arcturus Therapeutics Hldg I (ARCT) | 1.2 | $4.1M | 85k | 47.78 | |
Amicus Therapeutics (FOLD) | 1.2 | $4.1M | 425k | 9.55 | |
Edwards Lifesciences (EW) | 1.1 | $4.0M | 35k | 113.20 | |
Denali Therapeutics (DNLI) | 1.1 | $3.8M | 75k | 50.45 | |
Abbvie (ABBV) | 1.1 | $3.8M | 35k | 107.86 | |
Si-bone (SIBN) | 1.0 | $3.6M | 170k | 21.42 | |
Ptc Therapeutics I (PTCT) | 1.0 | $3.6M | 97k | 37.21 | |
Atara Biotherapeutics | 1.0 | $3.6M | 200k | 17.90 | |
Avalo Therapeutics | 1.0 | $3.5M | 1.6M | 2.18 | |
Mirati Therapeutics | 1.0 | $3.5M | 20k | 176.90 | |
Reata Pharmaceuticals Cl A | 1.0 | $3.5M | 35k | 100.60 | |
Nevro (NVRO) | 1.0 | $3.5M | 30k | 116.37 | |
Macrogenics (MGNX) | 1.0 | $3.4M | 160k | 20.94 | |
Aclaris Therapeutics (ACRS) | 1.0 | $3.3M | 185k | 18.00 | |
Aerie Pharmaceuticals | 0.8 | $2.9M | 250k | 11.40 | |
Biohaven Pharmaceutical Holding | 0.8 | $2.8M | 20k | 138.90 | |
Insmed Com Par $.01 (INSM) | 0.8 | $2.8M | 100k | 27.54 | |
Replimune Group (REPL) | 0.8 | $2.7M | 90k | 29.64 | |
Inspire Med Sys (INSP) | 0.7 | $2.3M | 10k | 232.90 | |
Regenxbio Inc equity us cm (RGNX) | 0.7 | $2.3M | 55k | 41.93 | |
Zymergen | 0.6 | $2.1M | 160k | 13.17 | |
Lyell Immunopharma (LYEL) | 0.6 | $2.1M | 140k | 14.80 | |
Akero Therapeutics (AKRO) | 0.5 | $1.9M | 85k | 22.35 | |
ImmunoGen | 0.5 | $1.7M | 300k | 5.67 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.5 | $1.7M | 350k | 4.81 | |
Myovant Sciences | 0.4 | $1.5M | 65k | 22.45 | |
Zymeworks | 0.4 | $1.5M | 50k | 29.04 | |
Precision Biosciences Ord | 0.4 | $1.4M | 125k | 11.54 | |
Revance Therapeutics (RVNC) | 0.4 | $1.4M | 50k | 27.86 | |
BioMarin Pharmaceutical (BMRN) | 0.4 | $1.4M | 18k | 77.28 | |
Forma Therapeutics Hldgs SHS | 0.4 | $1.4M | 60k | 23.18 | |
Kura Oncology (KURA) | 0.3 | $1.1M | 60k | 18.73 | |
Atea Pharmaceuticals (AVIR) | 0.3 | $1.1M | 30k | 35.07 | |
Agios Pharmaceuticals (AGIO) | 0.3 | $923k | 20k | 46.15 | |
Magenta Therapeutics | 0.2 | $655k | 90k | 7.28 | |
Protagonist Therapeutics (PTGX) | 0.2 | $620k | 35k | 17.71 | |
Chimerix (CMRX) | 0.2 | $557k | 90k | 6.19 | |
Longboard Pharmaceuticals In (LBPH) | 0.1 | $266k | 30k | 8.87 |